MDPI and ACS Style
Bahetibieke, S.; Moinuddin, S.M.; Baiyisaiti, A.; Liu, X.; Zhang, J.; Liu, G.; Shi, Q.; Peng, A.; Tao, J.; Di, C.;
et al. Co-Amorphous Formation of Simvastatin-Ezetimibe: Enhanced Physical Stability, Bioavailability and Cholesterol-Lowering Effects in LDLr−/−Mice. Pharmaceutics 2022, 14, 1258.
https://doi.org/10.3390/pharmaceutics14061258
AMA Style
Bahetibieke S, Moinuddin SM, Baiyisaiti A, Liu X, Zhang J, Liu G, Shi Q, Peng A, Tao J, Di C,
et al. Co-Amorphous Formation of Simvastatin-Ezetimibe: Enhanced Physical Stability, Bioavailability and Cholesterol-Lowering Effects in LDLr−/−Mice. Pharmaceutics. 2022; 14(6):1258.
https://doi.org/10.3390/pharmaceutics14061258
Chicago/Turabian Style
Bahetibieke, Shamuha, Sakib M. Moinuddin, Asiya Baiyisaiti, Xiaoang Liu, Jie Zhang, Guomin Liu, Qin Shi, Ankang Peng, Jun Tao, Chang Di,
and et al. 2022. "Co-Amorphous Formation of Simvastatin-Ezetimibe: Enhanced Physical Stability, Bioavailability and Cholesterol-Lowering Effects in LDLr−/−Mice" Pharmaceutics 14, no. 6: 1258.
https://doi.org/10.3390/pharmaceutics14061258